Abstract cell-like forms in teal, green and blue

A more precise approach to autoimmune disease.

We explore the biological pathways behind immune dysfunction to discover new possibilities for treatment.

Complex diseases.
A clear purpose.

Nexora Life Sciences is a UK biotechnology company investigating the mechanisms behind autoimmune disease. Our research asks how a deeper understanding of immune dysfunction could lead to more targeted treatments.

Our purpose is to connect discoveries in disease biology with opportunities for therapeutic development. We focus on the early research that helps establish where, how and why a potential medicine could make a difference.

From biological insight
to therapeutic possibility.

  1. 01

    Understand disease

    We study the biological mechanisms driving immune dysfunction, integrating multiple layers of data to build a clearer picture of disease biology.

  2. 02

    Identify targets

    We uncover and evaluate biological targets with the potential to modulate immune pathways in a precise and meaningful way.

  3. 03

    Advance discovery

    We apply deep biological insight and modern drug discovery approaches to advance novel therapeutic opportunities.

Following the biology.
Focusing our research.

We are investigating key areas of immune biology where there is strong rationale for therapeutic intervention, and where a deeper understanding could open up new possibilities for treating autoimmune disease.

Glass-like molecular structures in blue and green tones

A focused path through discovery.

  1. Target discovery

    Current focus

    Identify and characterise biological targets linked to immune dysfunction.

  2. Target validation

    Next research stage

    Generate and assess evidence to support the therapeutic potential of selected targets.

  3. Candidate development

    Longer-term ambition

    Progress the most promising opportunities towards development, in collaboration with specialist partners.

Ambitious questions.
Careful science.

We combine scientific rigour with a long-term perspective, recognising the complexity of immune-mediated diseases and the need for a thoughtful, evidence-led approach.

Shared expertise.
New possibilities.

We believe that progress in autoimmune disease will come from collaboration. We work with academic researchers, biotechnology companies and development partners to explore new ideas and advance promising science.

Work with us on
autoimmune research.

Whether it’s early research, a development programme or an idea worth testing, send us a note and our team will pick it up.